The global breast biopsy devices market size is estimated at USD 1.13 billion in 2025 and is predicted to reach around USD 1.64 billion by 2034, accelerating at a CAGR of 4.17% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Breast Biopsy Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Breast Biopsy Devices Market, by Product
8.1.1 Biopsy Needles
8.1.1.1. Market Revenue and Forecast
8.1.2. Guidance Systems
8.1.2.1. Market Revenue and Forecast
8.1.3. Biopsy Tables
8.1.3.1. Market Revenue and Forecast
8.1.4. Localization Wires
8.1.4.1. Market Revenue and Forecast
8.1.5. Assay Kits
8.1.5.1. Market Revenue and Forecast
8.1.6. Liquid Biopsy Instruments
8.1.6.1. Market Revenue and Forecast
8.1.7. Others
8.1.7.1. Market Revenue and Forecast
9.1. Breast Biopsy Devices Market, by Guidance
9.1.1. Image-Guided Biopsy
9.1.1.1. Market Revenue and Forecast
9.1.2. Mammography-guided Stereotactic Biopsy
9.1.2.1. Market Revenue and Forecast
9.1.3. Mammography-guided Stereotactic Biopsy
9.1.3.1. Market Revenue and Forecast
9.1.4. MRI-guided Biopsy
9.1.4.1. Market Revenue and Forecast
9.1.5. Other Guidance Techniques
9.1.5.1. Market Revenue and Forecast
9.1.6. Liquid Biopsy
9.1.6.1. Market Revenue and Forecast
9.1.7. NGS-based Biopsy
9.1.7.1. Market Revenue and Forecast
9.1.8. PCR-based Biopsy
9.1.8.1. Market Revenue and Forecast
9.1.9. Microarray-based Biopsy
9.1.9.1. Market Revenue and Forecast
10.1. Breast Biopsy Devices Market, by Type
10.1.1. Needle Breast Biopsy
10.1.1.1. Market Revenue and Forecast
10.1.2. Core Needle Biopsy (CNB)
10.1.2.1. Market Revenue and Forecast
10.1.3. Fine Needle Aspiration Biopsy (FNAB)
10.1.3.1. Market Revenue and Forecast
10.1.4. Vacuum-assisted Biopsy (VAB)
10.1.4.1. Market Revenue and Forecast
10.1.5. Open Surgical Breast Biopsy
10.1.5.1. Market Revenue and Forecast
10.1.6. Excisional
10.1.6.1. Market Revenue and Forecast
10.1.7. Incisional
10.1.7.1. Market Revenue and Forecast
10.1.8. Liquid Breast Biopsy
10.1.8.1. Market Revenue and Forecast
10.1.9. Circulating Tumor Cells
10.1.9.1. Market Revenue and Forecast
10.1.10. Circulating Tumor DNA (CtDNA)
10.1.10.1. Market Revenue and Forecast
10.1.11. Other Biomarkers
10.1.11.1. Market Revenue and Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product
11.1.2. Market Revenue and Forecast, by Guidance
11.1.3. Market Revenue and Forecast, by Type
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product
11.1.4.2. Market Revenue and Forecast, by Guidance
11.1.4.3. Market Revenue and Forecast, by Type
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product
11.1.5.2. Market Revenue and Forecast, by Guidance
11.1.5.3. Market Revenue and Forecast, by Type
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product
11.2.2. Market Revenue and Forecast, by Guidance
11.2.3. Market Revenue and Forecast, by Type
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product
11.2.4.2. Market Revenue and Forecast, by Guidance
11.2.4.3. Market Revenue and Forecast, by Type
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product
11.2.5.2. Market Revenue and Forecast, by Guidance
11.2.5.3. Market Revenue and Forecast, by Type
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product
11.2.6.2. Market Revenue and Forecast, by Guidance
11.2.6.3. Market Revenue and Forecast, by Type
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product
11.2.7.2. Market Revenue and Forecast, by Guidance
11.2.7.3. Market Revenue and Forecast, by Type
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product
11.3.2. Market Revenue and Forecast, by Guidance
11.3.3. Market Revenue and Forecast, by Type
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product
11.3.4.2. Market Revenue and Forecast, by Guidance
11.3.4.3. Market Revenue and Forecast, by Type
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product
11.3.5.2. Market Revenue and Forecast, by Guidance
11.3.5.3. Market Revenue and Forecast, by Type
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product
11.3.6.2. Market Revenue and Forecast, by Guidance
11.3.6.3. Market Revenue and Forecast, by Type
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product
11.3.7.2. Market Revenue and Forecast, by Guidance
11.3.7.3. Market Revenue and Forecast, by Type
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product
11.4.2. Market Revenue and Forecast, by Guidance
11.4.3. Market Revenue and Forecast, by Type
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product
11.4.4.2. Market Revenue and Forecast, by Guidance
11.4.4.3. Market Revenue and Forecast, by Type
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product
11.4.5.2. Market Revenue and Forecast, by Guidance
11.4.5.3. Market Revenue and Forecast, by Type
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product
11.4.6.2. Market Revenue and Forecast, by Guidance
11.4.6.3. Market Revenue and Forecast, by Type
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product
11.4.7.2. Market Revenue and Forecast, by Guidance
11.4.7.3. Market Revenue and Forecast, by Type
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product
11.5.2. Market Revenue and Forecast, by Guidance
11.5.3. Market Revenue and Forecast, by Type
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product
11.5.4.2. Market Revenue and Forecast, by Guidance
11.5.4.3. Market Revenue and Forecast, by Type
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product
11.5.5.2. Market Revenue and Forecast, by Guidance
11.5.5.3. Market Revenue and Forecast, by Type
12.1. Cook Medical Incorporated
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Becton, Dickinson and Company
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Devicor Medical Products Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. C.R. Bard, Inc., Hologic Inc
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Argon Medical Devices
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Planmed OY
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Encapsule Medical Devices LLC
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Ethicon Endo-Surgery (Johnson and Johnson)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at [email protected]
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client